A consortium ("the Consortium") consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China Everbright Limited's healthcare fund ("CEL Healthcare Fund"), and WuXi PharmaTech announced today that the Consortium ...
Tribute Pharmaceuticals Canada Inc., a specialty pharmaceutical company with a primary focus on...
Investors started shedding Achillion shares early Wednesday, less than a day after the drugmaker...
CVS Health will spend more than $10 billion to buy pharmacy services provider Omnicare and tap a...
US Pharma M&A activity has yet to show any signs of a slowdown after the $8.1bn exit of Par Pharma by TPG to Endo was announced on Monday. The US Pharma industry has seen 39 deals valued at US$ 77.3bn to-date, three more deals announced ...
Scientists have figured out all the steps to make morphine and similar painkillers without using opium poppies, potentially opening the door for home-brewed drugs. Some experts are calling for regulations to prevent tinkerers from making morphine, which can be converted into heroin.
Thousands of defendants convicted of drug crimes after a chemist in a state lab tampered with evidence can't be charged with more serious crimes or given harsher sentences if granted a new trial.
Three years ago a jury found that a subsidiary, Janssen Pharmaceutical, committed Medicaid fraud and violated a state law in its labeling and marketing of Risperdal. A $1.2 billion fine was initially imposed on Johnson & Johnson.
Boehringer Ingelheim and pharmaceutical company Pharmaxis announce that Boehringer Ingelheim has exercised its option and acquired the investigational drug PXS4728A, to develop it for the treatment of the liver-related condition NASH and ...
Endo International will spend about $8.05 billion to acquire Par Pharmaceutical as it pushes further into the generic drug market. Endo CEO Rajiv De Silva said the deal make Endo one of the top five generics companies as measured by U.S. sales.
Pharmaceutical Processing sat down with Rockwell Automation’s Paula Puess and Khris Kammer to get their take on recent market developments and what the future may hold for the pharmaceutical marketplace.
Pfizer Inc. today announced that it has received a request for additional information from the FTC with respect to its previously announced proposed acquisition of Hospira.
Dyadic International, Inc. is a global biotechnology company focused on enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries.
Treatment results with the breast cancer drug Herceptin, as well as chemotherapy, did improve, but the drug's backers had been hoping to see better results.
U.S. District Court Judge Charles Breyer said the acts alleged by prosecutors do not fall under an exemption in federal drug law for transportation companies such as FedEx.
Steps are being taken to resume executions in a state that hasn't imposed the death penalty since 1997.
Eli Lilly and Company and Sanford-Burnham Medical Research Institute today announced that they will collaborate to discover and develop immunological therapies.
Colombian President Santos last week decided to halt fumigation in the wake of a report by a research arm of the World Health Organization classifying (anti-coca) glyphosate as a probable carcinogen.
Thirteen percent of drugs marketed in the United States today post pharmacogenomic information on the label, but developers continue to encounter compliance challenges.
Attorneys for FedEx are set to appear in court, as they seek to dismiss a federal indictment that accuses the company of knowingly shipping illegal prescription drugs from two online pharmacies.
How pharmaceutical legal departments can create a competitive advantage for the enterprise.
TRACON Pharmaceuticals, a clinical stage biopharmaceutical company, today announced its financial results for the first quarter.
ProPharma Group, a compliance services company, today announced its acquisition of PROSAR, a provider of pharmacovigilance and medical information services.
Sigma-Aldrich Corporation has completed the expansion of its St. Louis facility to support commercial-scale antibody drug conjugate (ADC) manufacturing.
State senators, for a second time, have sent legislation legalizing medical marijuana to the House of Representatives, where the GOP majority has held hearings but given no certain signs of support.
ANI Pharmaceuticals has acquired the approved new drug application ("NDA") for a testosterone gel 1% product previously licensed to Teva Pharmaceuticals.
If the Supreme Court rules the way most Republicans want in the latest health overhaul case, GOP lawmakers who now have insurance coverage under President Barack Obama's law may wind up with some explaining to do.
Federal health advisers recommended approval for an experimental combination drug to treat cystic fibrosis, despite unresolved questions about the benefit of one of the pill's two ingredients.
- Page 1